International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
ICICSF-2025
IC-AIRCM-T³
Conferences Published ↓
SVGASCA (2025)
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 6
November-December 2025
Indexing Partners
Pharmacovigilance Review of Acyclovir: Mechanisms, Safety Profile, and Clinical Considerations
| Author(s) | Pallavi Prabhakar Patil, Umme Roman Shaikh |
|---|---|
| Country | India |
| Abstract | Acyclovir (ACV) is a guanine nucleoside analogue widely used for the treatment and prophylaxis of herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. Its mechanism of action involves selective phosphorylation by viral thymidine kinase, leading to inhibition of viral DNA polymerase and termination of viral DNA replication. While acyclovir exhibits a favorable safety profile, pharmacovigilance data have identified significant adverse drug reactions (ADRs), including nephrotoxicity due to crystalluria, neurotoxicity in renally impaired or elderly patients, and rare hematologic or severe cutaneous reactions. This review summarizes the pharmacokinetics, therapeutic applications, ADR patterns, drug–drug interactions, and considerations in special populations. Emphasis is placed on clinical interpretation, risk factors, dose adjustments, and strategies for early detection and prevention of ADRs. The review also highlights comparative safety with related antivirals and the role of post-marketing surveillance in optimizing patient safety. |
| Keywords | Acyclovir, Pharmacovigilance, Adverse drug reactions (ADRs), Nephrotoxicity, Neurotoxicity, Herpes simplex virus (HSV), Varicella-zoster virus (VZV), Drug–drug interactions, Special populations, Post-marketing surveillance. |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 6, November-December 2025 |
| Published On | 2025-11-27 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i06.62147 |
| Short DOI | https://doi.org/hbdsmp |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.